Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Cash & Equivalents (2021 - 2026)

Updated

Global Innovative Platforms (GIPL) recorded Cash & Equivalents of $244,235 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.4% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Cash & Equivalents (2021 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Global Innovative Platforms reported Cash & Equivalents of $17,828.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 244,235.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244,235.00
Mar 31, 2026 327,270.00
Sep 30, 2025 17,828.00
Jun 30, 2021 18,500.00
API Access

Global Innovative Platforms Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GIPL&period=max&api_key=YOUR_API_KEY